AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 149 filers reported holding AMICUS THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $1,161,000 | -8.2% | 93,000 | 0.0% | 0.07% | -13.9% |
Q1 2019 | $1,265,000 | +18.9% | 93,000 | -16.3% | 0.08% | -3.7% |
Q4 2018 | $1,064,000 | -20.8% | 111,100 | 0.0% | 0.08% | +10.8% |
Q3 2018 | $1,343,000 | -22.6% | 111,100 | 0.0% | 0.07% | -25.3% |
Q2 2018 | $1,735,000 | -14.5% | 111,100 | -17.7% | 0.10% | -5.7% |
Q1 2018 | $2,030,000 | -51.7% | 135,000 | -53.8% | 0.10% | -45.6% |
Q4 2017 | $4,202,000 | +53.2% | 292,000 | +60.5% | 0.19% | +59.5% |
Q3 2017 | $2,743,000 | +988.5% | 181,900 | +627.6% | 0.12% | +1000.0% |
Q2 2017 | $252,000 | +41.6% | 25,000 | 0.0% | 0.01% | +22.2% |
Q1 2017 | $178,000 | -5.8% | 25,000 | -34.2% | 0.01% | 0.0% |
Q4 2016 | $189,000 | -32.7% | 38,000 | 0.0% | 0.01% | 0.0% |
Q3 2016 | $281,000 | -93.6% | 38,000 | -92.7% | 0.01% | -95.4% |
Q1 2016 | $4,410,000 | +147.6% | 521,900 | +184.3% | 0.20% | +242.1% |
Q4 2015 | $1,781,000 | -9.1% | 183,592 | +31.1% | 0.06% | 0.0% |
Q3 2015 | $1,959,000 | -56.9% | 140,000 | -56.4% | 0.06% | -38.7% |
Q2 2015 | $4,547,000 | – | 321,336 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 10,114,043 | $116,817,000 | 7.46% |
Parametrica Management Ltd | 597,279 | $6,899,000 | 6.86% |
Redmile Group, LLC | 22,716,086 | $262,371,000 | 5.96% |
Perceptive Advisors | 53,118,886 | $613,524,000 | 4.73% |
Asymmetry Capital Management, L.P. | 716,709 | $8,278,000 | 4.39% |
CM Management, LLC | 450,000 | $5,198,000 | 3.93% |
Avoro Capital Advisors LLC | 18,500,000 | $213,675,000 | 3.64% |
Kynam Capital Management, LP | 573,699 | $6,626,000 | 3.54% |
SECTORAL ASSET MANAGEMENT INC | 1,242,882 | $14,355,000 | 2.16% |
Ghost Tree Capital, LLC | 500,000 | $5,775,000 | 2.07% |